T. Rowe Price Group

T. Rowe Price Group, Inc., established in 1937 and headquartered in Baltimore, Maryland, is a global investment management firm. It serves a diverse range of clients, including individuals, institutional investors, retirement plans, and financial intermediaries. The company offers a broad spectrum of investment strategies, focusing on equity and fixed income markets worldwide. T. Rowe Price employs a fundamental, bottom-up approach, combining in-house and external research, and considers environmental, social, and governance factors in its investment decisions. With offices across North America, Europe, Asia, and Australia, the firm is committed to delivering long-term investment excellence.

Oliver Bell

Associate Head of International Equities, Portfolio Manager, Member of the International Equity Steering Committee and Board Member of T. Rowe Price (Luxembourg) Management

David Eiswert

Vice President and Portfolio Manager

Matthew Frustaci

Investment Analyst

Germain, Jennifer St.

Vice President

John Hall

Investment Analyst

Moreland CPA, Kenneth Van

CFO and Treasurer

Simon Paterson

Equity Analyst

Past deals in Series D

Epirus

Series D in 2025
Epirus, Inc. is a technology company based in Hawthorne, California, specializing in the design and development of advanced defense systems that utilize artificial intelligence and directed energy. Founded in 2018, the company focuses on creating solid-state, software-defined high-power microwave solutions aimed at countering unmanned aircraft systems and other asymmetric threats. Its flagship product, ELECTROMAGNETIC PULSE, serves as a counter-infrastructure solution that can simultaneously target multiple threats, effectively neutralizing drones and swarms. By integrating AI and machine learning with advanced electronics, Epirus enhances the detection and tracking of objects of interest, offering innovative capabilities in electronic warfare and power management for both defense and commercial sectors.

Eikon Therapeutics

Series D in 2025
Eikon Therapeutics, Inc. is a biopharmaceutical company based in Hayward, California, focused on developing innovative treatments for chronic and life-threatening diseases. Founded in 2019, the company employs advanced super-resolution microscopy and live-cell imaging techniques to discover drugs targeting previously intractable proteins. By integrating biology, engineering, and chemistry, Eikon Therapeutics aims to enhance the understanding of cellular processes and improve drug discovery efficiency. Its proprietary platforms allow for the sensitive identification of compound-protein interactions, enabling the direct measurement of how chemical compounds affect individual proteins in live cells. This novel approach seeks to unlock new therapeutic opportunities and expand the company's pipeline of potential medications.

Clear Labs

Series D in 2025
Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company specializes in providing a comprehensive analytics platform that analyzes the molecular contents of food and ingredients. Its offerings include Clear Dx™ and Clear Safety™, which utilize next-generation sequencing and data analytics for food safety testing and infectious disease surveillance. Clear Labs serves food manufacturers, suppliers, and retailers by ensuring transparency throughout the supply chain and testing products for various factors such as authenticity, contamination, allergens, and nutritional content. The platform delivers actionable insights that enhance safety and operational efficiency while supporting public health initiatives. Through its integrated genomics system, Clear Labs aims to simplify complex diagnostics across clinical and applied markets, making genomic insights accessible to labs, hospitals, and businesses.

Lightmatter

Series D in 2024
Lightmatter, Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in developing AI hardware using integrated optical technology. The company's core product is a silicon chip that processes data using light signals instead of electrical signals, aiming to significantly accelerate AI computations. Lightmatter targets sectors such as artificial intelligence, cloud computing, and telecommunications, with a focus on improving efficiency and reducing power consumption in critical operations like image recognition and natural language processing.

Element Biosciences

Series D in 2024
Element Biosciences, Inc., established in 2017 and headquartered in San Diego, California, specializes in developing innovative genetic analysis tools for research and diagnostic markets. The company's core business revolves around its disruptive DNA sequencing technology, which encompasses surface chemistry, sequencing chemistry, detection methods, and data analysis. Element Biosciences aims to enhance accessibility to next-generation sequencing by offering a modular, high-performing platform that delivers high-quality data and workflow flexibility, thereby reducing run and capital costs.

Redwood Materials

Series D in 2023
Redwood Materials, Inc. is a Nevada-based company focused on advancing sustainable battery recycling technologies to create a circular supply chain for lithium-ion batteries. Founded by JB Straubel in 2017, Redwood specializes in the recycling and processing of end-of-life batteries and electronics to recover critical materials such as lithium, nickel, cobalt, copper, and various metals. The company currently receives approximately 10 GWh of used batteries annually and aims to scale its production of anode and cathode materials to 100 GWh by 2025, sufficient for manufacturing over one million electric vehicles each year. By providing environmentally sound solutions for recycling and refining, Redwood supports industries including electric vehicles, renewable energy storage, and consumer electronics, thereby contributing to a reduction in the environmental impact of battery production and usage.

FogPharma

Series D in 2022
FogPharma is a biotechnology company focused on developing innovative cancer therapies through its unique cell-penetrating mini proteins (CPMPs). Founded by Greg Verdine, the company aims to address cancer-causing proteins that are typically inaccessible to traditional treatments. By collaborating with leading experts in cancer biology and therapy, FogPharma is creating a new class of medicines designed to neutralize these challenging targets. The company is supported by a diverse group of private and institutional investors, which enables it to pursue its mission of delivering transformative cancer treatments. FogPharma is dedicated to improving the lives of patients and their families, striving to extend both life expectancy and quality of life.

Jetti Resources

Series D in 2022
Jetti Resources is a company based in Vancouver, Canada, that specializes in developing hydrometallurgical technology for the extraction of metals from mineral ores. Founded in 2014, Jetti focuses primarily on extracting copper from low-grade primary sulfides, including chalcopyrite, which is the most abundant copper mineral ore. The company has developed a proprietary catalytic technology that enhances copper recovery from vast quantities of ore, addressing significant challenges in mineral processing. This technology integrates with existing heap leaching methods and downstream operations, allowing industrial clients to improve copper yields in a cost-effective and environmentally sustainable manner. Additionally, Jetti's technology is applicable for the extraction of zinc and nickel from sulfide ores, further diversifying its capabilities in mineral processing.

Celonis

Series D in 2022
Celonis is a company that specializes in execution management, focusing on optimizing and analyzing business processes across various industries, including production, human resources, and logistics. Its core product, the Celonis Execution Management System (EMS), utilizes advanced process mining technology to enhance productivity and streamline operations. The EMS provides a comprehensive suite of tools and applications, including Celonis Studio, designed for business executives and users to effectively manage execution across analytics, strategy, planning, and automation. By offering unique software solutions, Celonis enables organizations to improve process transparency and efficiency, ultimately unlocking their full execution capacity.

Flexe

Series D in 2022
Flexe, Inc. operates a cloud-based marketplace that connects organizations seeking additional warehousing and fulfillment services with those that have surplus capacity. Founded in 2013 and headquartered in Seattle, the company specializes in omnichannel logistics solutions, including eCommerce fulfillment, retail distribution, and same-day delivery. Flexe's platform addresses the challenges of inventory overflow and fulfillment needs by creating an open logistics network, allowing clients such as retailers, wholesalers, manufacturers, and logistics companies to optimize their distribution capabilities. By integrating technology and flexible economic models, Flexe enables its customers to enhance their operational efficiency and respond swiftly to market demands.

Cross River Bank

Series D in 2022
Cross River Bank, established in 2008 and headquartered in Fort Lee, New Jersey, is a subsidiary of CRB Group, Inc. It offers a range of personal and corporate banking services, including checking, savings, and deposit accounts. The bank specializes in direct lending for commercial real estate projects across the New York, New Jersey, and Connecticut metro areas. Notably, Cross River Bank combines traditional banking with innovative technologies to provide solutions for fintech companies in marketplace lending and payment processing. It focuses on regulatory compliance and consumer protection to deliver secure, API-based banking platforms and products, encompassing lending, payments, risk management, and BaaS offerings, enabling a comprehensive banking experience for its clients.

SandboxAQ

Series D in 2022
SandboxAQ is a company that develops artificial intelligence and quantum technology solutions aimed at addressing complex business and scientific challenges. By integrating expertise from multiple disciplines, including physics, computer science, and mathematics, the company creates Large Quantitative Models and AI sensing applications tailored for various industries. Its offerings are designed to provide practical solutions in sectors such as financial services, healthcare, telecommunications, and cybersecurity. Through its innovative software, SandboxAQ enables clients to tackle significant computational challenges and advance their technological capabilities.

CelLink

Series D in 2022
CelLink Corporation is an innovative company focused on developing flexible conductive backplanes and circuits for power electronics, including applications in batteries, solar panels, light-emitting diodes, and wire harnessing. Founded in 2012 and based in Belmont, California, CelLink manufactures high-conductance, large-area flexible circuits designed to facilitate clean power transmission. Their products integrate essential components such as busing, fusing, and voltage and temperature monitoring into a single circuit, providing customers with efficient solutions for power and data transmission at competitive prices. By offering advanced technology in a growing market, CelLink aims to support the increasing demand for sustainable energy solutions.

Freenome

Series D in 2021
Freenome, Inc. is an artificial intelligence genomics biotech company based in South San Francisco, California, founded in 2014. The company focuses on developing accurate, accessible, and non-invasive blood tests for the early detection of cancer and treatment selection. Utilizing a proprietary multi-omics platform, Freenome employs advanced algorithms to analyze cell-free genomic data, which aids in identifying early-stage cancers and other diseases. This innovative approach aims to transform disease management by enabling timely interventions and proactive treatment strategies. In addition to its diagnostic solutions, Freenome also offers clinical research services to further advance cancer detection and management.

Nuro

Series D in 2021
Nuro, Inc. is a technology company based in Mountain View, California, that specializes in the development of self-driving vehicles specifically designed for local goods transportation. Incorporated in 2016, Nuro aims to transform local commerce through its fleet of fully autonomous, electric vehicles that facilitate the delivery of a wide range of products, including food and pharmaceuticals. By enabling retailers to efficiently and safely deliver goods to customers, Nuro enhances the convenience of local commerce and meets the growing demand for autonomous delivery solutions.

Rad Power Bikes

Series D in 2021
Rad Power Bikes LLC, based in Seattle, Washington, is a leading manufacturer and retailer of electric bicycles in North America. Founded in 2015, the company specializes in designing feature-rich e-bikes suitable for both on and off-road use, catering to a diverse range of consumer needs. In addition to its electric bikes, Rad Power Bikes offers a variety of accessories such as bags, fenders, racks, and safety products, as well as replacement parts like batteries and tires. The company operates on a direct-to-consumer model, selling its products primarily through online platforms, which allows it to provide affordable and accessible transportation solutions. With a rapidly expanding workforce exceeding 700 employees, Rad Power Bikes is committed to revolutionizing electric mobility and promoting energy-efficient transportation options.

Celonis

Series D in 2021
Celonis is a company that specializes in execution management, focusing on optimizing and analyzing business processes across various industries, including production, human resources, and logistics. Its core product, the Celonis Execution Management System (EMS), utilizes advanced process mining technology to enhance productivity and streamline operations. The EMS provides a comprehensive suite of tools and applications, including Celonis Studio, designed for business executives and users to effectively manage execution across analytics, strategy, planning, and automation. By offering unique software solutions, Celonis enables organizations to improve process transparency and efficiency, ultimately unlocking their full execution capacity.

Capsule

Series D in 2021
Capsule Corporation is an online retail pharmacy founded in 2015 and based in New York. The company focuses on transforming the pharmacy industry by providing a digital platform that facilitates the delivery of prescription medications. Capsule’s service allows patients to receive same-day delivery of their prescriptions and enables them to switch refills from their previous pharmacies. By leveraging technology, Capsule aims to improve the pharmaceutical experience for patients, doctors, hospitals, insurers, and manufacturers, emphasizing the importance of personal care within the healthcare system. Capsule has successfully raised $70 million in funding to support its mission of enhancing pharmacy services.

LUMICKS

Series D in 2021
LUMICKS specializes in advanced technologies for studying biology and cancer at the single-molecule and single-cell levels. The company focuses on bridging the gap between molecular structure and function, providing tools that enable real-time analysis of complex biological processes. Its flagship product, the C-Trap Optical Tweezers, combined with Fluorescence Microscopy, allows scientists to observe interactions at the single-molecule level. Additionally, the z-Movi Cell Avidity Analyzer measures and selects immune cells based on their real-time interactions with target cells. By facilitating live measurement and imaging, LUMICKS' instruments provide critical insights into the fundamental causes of diseases, including cancer, and hold potential for optimizing drug development.

Color

Series D in 2021
Color is a healthcare technology company that offers a comprehensive platform for population health management, facilitating equitable and accessible healthcare delivery. The company specializes in large-scale health initiatives, providing solutions that include population genomics programs and high-throughput testing services, such as those for COVID-19. By centralizing essential healthcare capabilities, Color enables businesses, schools, and state public health departments to implement effective preventive health programs, regardless of the geographical distribution of their populations. Its innovative approach addresses various healthcare logistics challenges, streamlining processes related to testing, screening, treatment, and referrals, while creating diverse market opportunities and revenue streams for clinical teams.

Honor

Series D in 2020
Honor is a leading senior care network and technology platform that focuses on enhancing the quality of life for older adults and their families. Founded in 2014 by Cameron Ring, Monica Lo, Sandy Jen, and Seth Sternberg in San Francisco, California, Honor has established itself as a pioneer in the home care industry. The company offers expert in-home care services for seniors, leveraging an integrated system of third-party care providers. By combining scalable workforce management with personalized care, Honor enables older adults to live safely and comfortably in their own homes. In 2021, Honor expanded its reach by acquiring Home Instead, enhancing its capabilities through a global network and a relationship-based care model. This strategic move positions Honor to address the evolving needs of aging adults and professional caregivers worldwide.

Seer

Series D in 2020
Seer, Inc. is a life sciences company that specializes in nanoparticle technology solutions aimed at advancing proteomics research. The company offers Proteograph, an integrated system that includes consumables, automation instrumentation, and proprietary software for conducting proteomics analysis. Seer's products are designed for research applications, targeting academic institutions, life sciences laboratories, and biopharmaceutical companies for non-diagnostic and non-clinical uses. Additionally, Seer is focused on developing a health data platform that enhances early detection of chronic diseases by capturing and translating molecular insights from the proteome, thereby enabling healthcare professionals to identify conditions such as cancer and neurological disorders more accurately and rapidly. Founded in 2017 and headquartered in Redwood City, California, Seer was previously known as Seer Biosciences, Inc. before rebranding in July 2018.

Atea Pharmaceuticals

Series D in 2020
Atea Pharmaceuticals is a clinical-stage biopharmaceutical company based in Boston, Massachusetts, that focuses on discovering and developing antiviral therapies for severe viral infections. The company's lead candidate, AT-527, is an antiviral agent currently undergoing phase 3 clinical trials for the treatment of COVID-19, caused by SARS-CoV-2. Additionally, Atea is developing several other product candidates, including AT-787, which is in phase 2 trials for hepatitis C, and AT-752 for dengue. Other candidates, such as AT-889 and AT-934, are also in phase 2 clinical trials targeting respiratory syncytial virus. Established in 2014, Atea Pharmaceuticals aims to improve treatment options for patients suffering from serious viral infections.

RefleXion Medical

Series D in 2020
RefleXion Medical Inc. is a medical equipment company specializing in the development of biologically-guided radiotherapy systems for cancer treatment. Its flagship innovation, the RefleXion X1 machine, is designed to deliver advanced radiation therapies such as stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS). The company's biologically-guided radiotherapy (BgRT) technology utilizes positron-emission tomography (PET) imaging data to allow tumors to continuously signal their location during treatment, enabling the possibility of treating multiple tumors in a single session, especially in cases of metastasized cancers. This real-time adaptation to the biological characteristics of tumors represents a significant advancement in radiation oncology. RefleXion Medical, incorporated in 2009 and based in Hayward, California, has established strategic partnerships with Telix Pharmaceuticals Limited and HealthMyne Inc. to further its mission in cancer treatment innovation.

Color

Series D in 2020
Color is a healthcare technology company that offers a comprehensive platform for population health management, facilitating equitable and accessible healthcare delivery. The company specializes in large-scale health initiatives, providing solutions that include population genomics programs and high-throughput testing services, such as those for COVID-19. By centralizing essential healthcare capabilities, Color enables businesses, schools, and state public health departments to implement effective preventive health programs, regardless of the geographical distribution of their populations. Its innovative approach addresses various healthcare logistics challenges, streamlining processes related to testing, screening, treatment, and referrals, while creating diverse market opportunities and revenue streams for clinical teams.

Rivian

Private Equity Round in 2019
Rivian is an automotive technology company that develops products and services to advance the shift to sustainable mobility. The company creates solutions that redefine traditional automotive economics and remove the pain points of conventional ownership. It also manufactures autonomous electric vehicles intended to offer a comfortable and eco-friendly driving experience.

Seer

Series D in 2019
Seer, Inc. is a life sciences company that specializes in nanoparticle technology solutions aimed at advancing proteomics research. The company offers Proteograph, an integrated system that includes consumables, automation instrumentation, and proprietary software for conducting proteomics analysis. Seer's products are designed for research applications, targeting academic institutions, life sciences laboratories, and biopharmaceutical companies for non-diagnostic and non-clinical uses. Additionally, Seer is focused on developing a health data platform that enhances early detection of chronic diseases by capturing and translating molecular insights from the proteome, thereby enabling healthcare professionals to identify conditions such as cancer and neurological disorders more accurately and rapidly. Founded in 2017 and headquartered in Redwood City, California, Seer was previously known as Seer Biosciences, Inc. before rebranding in July 2018.

Convoy

Series D in 2019
Convoy, Inc. operates an online marketplace that provides digital freight network services, enabling users to book local and regional trucks on demand for transporting goods, ranging from single pallets to full truckloads. The company offers a mobile application that features real-time shipment tracking, status updates, and ensures on-time deliveries. Founded in 2015 and based in Seattle, Washington, Convoy aims to enhance efficiency in the trucking industry, which is valued at $800 billion and is responsible for significant carbon emissions from empty trucks. By utilizing technology and data, Convoy addresses issues of waste and inefficiency, ultimately saving money for shippers, increasing earnings for drivers, and reducing carbon waste. The platform facilitates instant quotations, online bookings, automated loading suggestions, and online payments, all of which contribute to improved operational efficiency and cost reduction for clients.

Checkr

Series D in 2019
Checkr, Inc. is a technology-driven company focused on the background check industry, offering a comprehensive range of screening services, including criminal record checks, driving checks, and identity verification. Founded in 2014 and headquartered in San Francisco, California, Checkr utilizes advanced technology and data sources to deliver faster and more efficient background checks compared to traditional providers. The company emphasizes fairness and transparency in hiring, enabling businesses across various sectors, including financial services, healthcare, and staffing, to enhance their hiring processes. Checkr also provides compliance services and security solutions, ensuring a secure and streamlined experience for both employers and candidates. With its innovative platform, Checkr aims to improve the overall applicant experience while supporting companies in navigating the complexities of today's workforce dynamics.

Wheels Up Partners

Series D in 2019
Wheels Up is a membership-based private aviation company that specializes in on-demand flight services in the United States. By leveraging data and technology, it connects consumers with safety-vetted private aircraft, offering both programmatic and charter options. The company aims to reduce the upfront costs associated with private flying while providing flexibility, service, and safety to its members. Through its mobile app, users can easily book flights, manage accounts, and access ride-share opportunities. Additionally, members participate in the Wheels Down program, which enhances their travel experiences. Wheels Up operates a diverse fleet, utilizing owned, leased, and chartered aircraft to provide a wide range of global travel alternatives.

Gusto

Series D in 2019
Gusto is a software-as-a-service company specializing in Human Capital Management (HCM). It offers a comprehensive platform that simplifies payroll processing, benefits administration, and employee management for small businesses. Gusto’s services include payroll management, time and attendance tracking, and employee onboarding, all designed to meet the various HR needs of its clients. By providing an integrated system for managing employee benefits, including health, dental, and vision insurance, Gusto enables businesses to effectively support their workforce. This platform is aimed at streamlining administrative tasks, allowing small business owners to focus on their core operations while ensuring compliance with employment regulations.

Xometry

Series D in 2019
Xometry Inc. is a provider of on-demand manufacturing services, specializing in various advanced production techniques, including 3D printing, CNC machining, injection molding, and urethane casting. Established in 2013 and headquartered in Gaithersburg, Maryland, with an additional office in Bethesda, the company operates an AI-enabled marketplace that facilitates the efficient sourcing of custom-manufactured parts and assemblies. Xometry's diverse offerings include rapid prototyping, volume production, mechanical assembly, and aftermarket solutions, catering to a wide range of clients, including engineers, product designers, and business owners. The company has a strategic partnership with Roush Yates Manufacturing Solutions, further enhancing its capabilities in the manufacturing sector. Xometry is organized into U.S. and International segments, with the majority of its revenue generated from the U.S. market.

UiPath

Series D in 2019
UiPath Inc. specializes in designing and developing robotic process automation software for enterprises, aiming to enhance business efficiency through automation. Its comprehensive platform enables hyper-automation by identifying automation opportunities driven by artificial intelligence and human collaboration. The solution facilitates the creation, management, deployment, and optimization of automation across various business processes, including finance, healthcare, human resources, and legal operations. By utilizing a combination of robotic process automation and application programming interfaces, UiPath allows organizations to automate repetitive tasks, offering enhanced control and governance, with deployment options available both in the cloud and on-premises. Founded in 2005 and headquartered in New York, UiPath serves a diverse range of industries, including finance, insurance, telecommunications, and public sector entities.

1stdibs

Series D in 2019
1stdibs is an online marketplace dedicated to connecting design enthusiasts with sellers and makers of a wide range of rare and desirable items, including vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The platform serves as a meeting point for respected dealers and collectors who share an appreciation for exquisite design. 1stdibs generates revenue primarily through fees for seller marketplace services, as well as additional income from advertisements and software solutions provided to interior designers through its separate platform, Design Manager. This dual focus enables the company to cater to both individual collectors and professionals in the design industry.

ShockWave Medical

Series D in 2018
ShockWave Medical, Inc. is a medical device company based in Santa Clara, California, focused on developing and commercializing intravascular lithotripsy technology to treat calcified plaque associated with peripheral vascular, coronary vascular, and heart valve diseases. The company offers a range of catheters, including M5 for above-the-knee peripheral artery disease, C2 for coronary artery disease, and S4 for below-the-knee peripheral artery disease. Its Lithoplasty™ technology utilizes sonic pressure waves to facilitate the treatment of rigid vascular and valvular lesions, allowing for improved angioplasty outcomes and reduced reliance on stents. This innovative approach enhances vessel preparation before procedures such as drug eluting balloon placement and trans-catheter aortic valve replacement. ShockWave Medical serves a diverse clientele, including interventional cardiologists, vascular surgeons, and interventional radiologists, through a network of sales representatives, managers, and distributors across the United States and Europe. Incorporated in 2009, the company is committed to transforming cardiovascular care and improving patient outcomes.

ServiceTitan

Series D in 2018
ServiceTitan, Inc. offers a cloud-based business management software specifically designed for the home and commercial service industries. Founded in 2007 and headquartered in Glendale, California, with additional offices in Atlanta and Armenia, the company provides a comprehensive solution that includes tools for dispatching, scheduling, invoicing, customer relationship management, marketing automation, and custom reporting. Its software serves a diverse range of sectors, including HVAC, plumbing, electrical, and other home service businesses, helping them streamline operations, enhance customer service, and foster growth. By integrating various systems and providing end-to-end capabilities, ServiceTitan enables businesses to modernize their operations and improve efficiency in an industry that has historically been underserved by technology.

PagerDuty

Series D in 2018
PagerDuty, Inc. is a digital operations management platform that specializes in real-time operations, enabling businesses to effectively manage urgent and mission-critical tasks. Founded in 2009 and headquartered in San Francisco, the company offers a software-as-a-service (SaaS) solution that integrates digital signals from various software-enabled systems with human response data. This allows organizations to take appropriate actions in real-time, enhancing their ability to respond to incidents and disruptions. PagerDuty's platform includes features such as event intelligence, incident response, on-call management, and advanced analytics, which cater to a diverse array of industries including technology, telecommunications, retail, and financial services. With over 10,000 global customers, including notable brands like Comcast and Slack, PagerDuty empowers businesses to maintain operational efficiency and improve customer satisfaction by proactively managing incidents that could impact their service delivery.

Outset Medical

Series D in 2018
Outset Medical, Inc. is a medical technology company based in San Jose, California, focused on innovating hemodialysis systems. The company has developed Tablo, a compact dialysis machine designed for use in both acute and chronic care settings. This system integrates essential features such as water purification, on-demand dialysate production, and advanced software capabilities, including wireless data connectivity and sensor-based automation. By simplifying the dialysis process, Tablo aims to reduce costs and enhance the experience for both patients and healthcare providers. Founded in 2003 and originally named Home Dialysis Plus, Ltd., Outset Medical rebranded in 2015 to reflect its commitment to transforming dialysis care.

Evolve

Series D in 2018
Evolve is a hospitality company with a mission to make renting a vacation home easy for both guests and homeowners. They help guests rest easy knowing our homes are verified, our support is 24/7, and if their stay doesn’t meet our standards, we’ll make it right. We also make vacation rental stress-free for homeowners, partnering with them to book more and keep more of what they earn thanks to our industry-low 10% management fee.

Toast

Series D in 2018
Toast, Inc. is a Boston-based restaurant technology company that specializes in developing an all-in-one point-of-sale and restaurant management platform tailored for the food service and hospitality industries. Founded in 2011, Toast offers a cloud-based system designed specifically for restaurants, enabling functionalities such as tableside ordering, real-time reporting, online ordering, and labor management. The platform serves a diverse clientele, including restaurants, cafés, bars, and bakeries, and supports over 120,000 locations across the United States. Toast generates revenue through software subscription fees, transaction processing commissions, and additional services such as hardware installation and professional support. By facilitating payment transactions on its platform, Toast processed approximately $126 billion in gross volume in 2023, demonstrating its significant role in the restaurant technology landscape.

D2iQ

Series D in 2018
D2iq, Inc. is a technology company that specializes in developing a datacenter operating system (DCOS) to streamline the management and deployment of applications across physical and cloud-based infrastructures. Founded in 2013 and headquartered in San Francisco, D2iq's core product, Mesosphere DCOS, is built on open-source technology and simplifies the execution of applications in a data center environment, akin to launching apps on a personal computer. The company also offers solutions such as Mesosphere Infinity, which facilitates the transformation of Big Data into actionable insights, and Conductor, an interactive platform for hands-on cloud-native training. In addition to its software offerings, D2iq provides architectural and consulting services, including expert consultations, on-site training, and custom installations. The company's strategic alliances with prominent firms enhance its service offerings, enabling organizations to adopt open-source and cloud-native innovations effectively.

Tempus

Series D in 2018
Tempus, established in 2015 and based in Chicago, Illinois, is a technology company specializing in precision medicine. It develops a comprehensive library of molecular and clinical data, along with an operating system that makes this information accessible and useful for patients, physicians, and researchers. Tempus offers services such as genomic sequencing, clinical data restructuring, and biological modeling, enabling real-time data-driven decisions for personalized patient care and facilitating the discovery of optimized therapeutic options.

Farmers Business Network

Series D in 2017
Farmers Business Network, Inc. is an independent agricultural technology and commerce platform that serves as a farmer-to-farmer network, empowering its members to make informed decisions to enhance the economic viability of their farms. The company advocates for family farmers and ranchers by providing data-driven agronomic insights, facilitating direct purchases from manufacturers, and enabling competitive market opportunities for selling crops. Farmers can leverage the network to share information and access vital resources such as health and crop insurance. With a membership that spans over 80 million acres across the U.S., Canada, and Australia, Farmers Business Network employs over 800 personnel and operates offices in key locations, including San Carlos, California, Chicago, Illinois, Sioux Falls, South Dakota, and its Canadian and Australian headquarters in High River, Alberta, and Perth, respectively.

Magic Leap

Series D in 2017
Magic Leap is an American startup specializing in Augmented Reality (AR) technology. The company develops proprietary wearable hardware that merges digital imagery with the real world, creating immersive AR experiences indistinguishable from reality. Their innovative Dynamic Digitized Lightfield Signal generates computer-generated 3D images that harmonize with human senses, enabling users to interact with digital devices in a visually cinematic manner. Magic Leap aims to redefine how users access screens and visualize data by combining inherent visual ability with mobile computing technology.

Quanterix

Series D in 2017
Quanterix Corporation is a life sciences company focused on developing an ultra-sensitive digital immunoassay platform to advance precision health in diagnostics and research. Their proprietary technology, Simoa, enables the detection of protein biomarkers at very low concentrations in biological samples such as blood and serum, which are often undetectable using traditional methods. This high level of sensitivity allows for earlier disease detection, improved prognosis, and more precise treatment methods. Quanterix's platforms include bead-based and planar array systems designed to provide reliable and robust assay performance, addressing various unmet medical needs in clinical diagnostics, drug development, and life science research.

AveXis

Series D in 2015
AveXis, now known as Novartis Gene Therapies, is a biotechnology company focused on developing and commercializing gene therapies aimed at treating rare and life-threatening neurological genetic disorders. Acquired by Novartis in 2018, the company specializes in motor neuron cell-targeted gene replacement therapies for conditions such as spinal muscular atrophy, Rett syndrome, and amyotrophic lateral sclerosis. By addressing these severe diseases, which often result in progressive muscle weakness, paralysis, and death, AveXis plays a crucial role in enhancing treatment options for affected patients and their families.

Warby Parker

Series D in 2015
Warby Parker is a lifestyle brand specializing in the design and sale of vintage-inspired eyewear, including prescription glasses and sunglasses. The company operates as a socially conscious business, aiming to provide affordable eyewear to those in need. For every pair of glasses sold, Warby Parker donates a pair to a person in need through partnerships with non-profit organizations. The company generates revenue through the sales of its eyewear products, optical services, and accessories, primarily via its stores, website, and mobile apps.

WeWork

Series D in 2014
WeWork is a global commercial real estate company that transforms buildings into collaborative workspaces, catering to a wide range of clients from freelancers to Fortune 500 companies. Founded in 2010, it provides flexible, serviced office spaces along with infrastructure, services, and technology to foster productivity and creativity. With over 20,000 members worldwide, WeWork aims to create a community where people can work to make a life, not just a living. Its revenue streams include membership fees for office space access and additional billings for ancillary services. WeWork also operates WeWork Labs, a platform supporting early-stage startups, and has a presence in China and India through its subsidiaries.

Houzz

Series D in 2014
Houzz Inc. is an online platform dedicated to home design and furnishings, connecting homeowners, design enthusiasts, and home improvement professionals globally. Established in 2008 and headquartered in Palo Alto, California, Houzz offers a comprehensive range of services, enabling users to find design inspiration, hire professionals, and shop for home products, including kitchen, bath, and outdoor items. The platform features the largest residential design database in the world, facilitating the sharing of ideas and advice within a vibrant community. Additionally, Houzz Pro provides a Software-as-a-Service solution for professionals in the home remodeling and design sectors, helping them manage their businesses effectively. The company has expanded its reach with offices in key international locations, including London, Berlin, Sydney, Moscow, and Tokyo.

Airbnb

Series D in 2014
Airbnb, Inc., established in 2007, operates a global online platform that connects hosts offering accommodations with guests seeking short-term stays. Its diverse listings range from private rooms and luxury villas to unique stays and boutique hotels, totaling over 8 million active listings worldwide. Airbnb facilitates bookings and provides management tools for both hosts and guests, generating revenue through transaction fees. As of 2023, North America contributes to 50% of its revenue.

Evernote

Series D in 2012
Evernote Corporation is a software company that develops and markets applications designed for mobile phones, tablets, and computers, catering to both individuals and businesses globally. Founded in 2004 and headquartered in Redwood City, California, Evernote provides a suite of tools that facilitate note-taking, organization, and information management. Its flagship application allows users to write, collect, and present ideas seamlessly across devices. Additional offerings include Skitch, which enables visual communication through annotations and sketches; Scannable, which transforms paper documents into digital scans; Evernote Web Clipper, for saving web content; and Penultimate, a handwriting app for iPad. With a user base exceeding 100 million, Evernote's innovative solutions aim to enhance productivity and streamline workflows for its customers. The company operates independently and continues to expand its offerings and team.

Castlight Health

Series D in 2012
Castlight is on a mission to make it as easy as humanly possible for people to navigate the healthcare system, and live happier, healthier, more productive lives. They as a leader in healthcare navigation, we provide a world-class digital platform with a team of clinical, and benefits experts to help members easily connect, and engage with the right programs and care, at the right time. Castlight partners with companies, and health plans to transform employee, and member benefits into one comprehensive health, and wellbeing experience to deliver better health outcomes, and maximize returns on healthcare investments.

Upwork Global

Series D in 2012
Upwork Global Inc. operates an online talent marketplace that connects businesses with independent professionals and agencies worldwide, primarily in the United States, India, and the Philippines. The platform offers access to a diverse pool of talent with around 8,000 skills across various categories, including web development, graphic design, and customer service. Upwork facilitates streamlined workflows for clients, encompassing talent sourcing, contracting, and project management through features like communication tools, time tracking, invoicing, and payment processing. The company provides several service tiers, including Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll, catering to different client needs. Founded in 1998 and originally known as Elance-oDesk, Upwork rebranded in May 2015 and is headquartered in Santa Clara, California, with additional offices in major cities. The platform serves a wide range of clients, from startups to large enterprises, generating significant revenue through its comprehensive freelance services.

Apptio

Series D in 2012
Apptio, Inc. is a provider of cloud-based Technology Business Management (TBM) solutions designed to assist enterprises in managing their IT investments effectively. Founded in 2007 and headquartered in Bellevue, Washington, Apptio offers a suite of applications that leverage business analytics to deliver insights on technology costs, value, and quality. This enables IT leaders to make informed, data-driven decisions that align technology spending with business outcomes. The company’s solutions encompass cost transparency, benchmarking, operational efficiency, and planning, facilitating automation of IT processes. Apptio's technology operates on a next-generation, in-memory cost analytics platform that aggregates and analyzes data from various financial, operational, and billing sources, providing users with deep visibility into the total cost of IT services. The company serves a global market, with operations in several countries, including the United States, the United Kingdom, Germany, and Australia.

X (formerly Twitter)

Series D in 2009
Twitter is a social networking platform that facilitates the exchange of micro-blogs, known as "tweets," which can be up to 280 characters in length. Launched in 2006, it allows users to send and read tweets through various means, including web browsers, SMS, and mobile applications. With over 400 million monthly visitors and 255 million active users, Twitter serves as a global real-time communications platform. Its diverse user base includes world leaders, athletes, entertainers, and news organizations, contributing to its role as a significant source of information and engagement. The platform is available in more than 35 languages and has a strong presence in major cities worldwide, with headquarters in San Francisco and offices across the United States and internationally.

Slide

Series D in 2008
Slide, founded by PayPal co-founder Max Levchin, makes widgets that help people express themselves. The company took a big risk in 2006 when they gave users the ability to auto-insert slide shows into their MySpace pages and blasting bulletins out to all their friends. They did this by asking users to hand over their MySpace credentials, and doing all the hard work for them. This is a clear violation of MySpace's terms of service, though, and most people expected Slide to receive a cease and desist letter and/or get access turned off. But that never happened, and Slide's big bet has paid off. Slide has since evolved to offer a number of widgets. Users create and personalize widgets on Slide.com and can then use them on social networks, blogs and desktops. According to comScore Slide has more than 117 million unique monthly viewers. Slide also claims more than 200,000 new Slide Shows are added to the Slide Network each day.

CymaBay Therapeutics

Series D in 2007
CymaBay Therapeutics is a clinical-stage biopharmaceutical company based in Newark, California, dedicated to developing therapies for liver and other chronic diseases with significant unmet medical needs. The company's lead product candidate, seladelpar, is a selective agonist of the peroxisome proliferator-activated receptor delta, which has completed Phase II clinical studies targeting conditions such as primary biliary cholangitis and sclerosing cholangitis, as well as nonalcoholic steatohepatitis. Additionally, CymaBay is developing MBX-2982, a selective oral G protein-coupled receptor agonist aimed at treating gut and liver diseases. The company also has a preclinical candidate, CB-001, which targets omega-3 fatty acid receptors. CymaBay has entered into development and licensing agreements with other pharmaceutical firms to explore treatments for metabolic diseases, including type 2 diabetes and gout. The company's commitment to advancing its pipeline reflects its focus on creating innovative medicines that can improve patient outcomes.

Alexza Pharmaceuticals

Series D in 2005
Alexza Pharmaceuticals, Inc. is a pharmaceutical company based in Mountain View, California, dedicated to the research, development, and commercialization of proprietary products for the acute treatment of central nervous system conditions. The company utilizes its innovative Staccato system, a hand-held inhaler that vaporizes drugs into a condensation aerosol for rapid systemic delivery when inhaled. Its primary product, ADASUVE, contains Staccato loxapine and is intended for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults. Additionally, Alexza is developing AZ-002, which is Staccato alprazolam for acute repetitive seizures, and AZ-007, Staccato zaleplon for insomnia. The company was founded in 2001 and was formerly known as Alexza Molecular Delivery Corporation before rebranding in 2005. As of 2016, it operates as a subsidiary of Ferrer Therapeutics, Inc.

DoubleTwist

Series D in 2000
In December 1999, Pangea Systems became DoubleTwist, Inc. - a new application service provider (ASP)/ Internet company devoted to empowering life scientists. The change reflects a new focus on this Internet portal. DoubleTwist.com integrates powerful tools and data behind automated research agents that retrieve and interpret data based on the user's scientific questions. The company's traditional data warehousing and mining software power the site, enabling life science research through an easy-to-use interface on the Web. DoubleTwist has established a talented and experienced development team of scientific and technical personnel dedicated to building software solutions that address the biological data management needs of life scientists. DoubleTwist's scientific team is comprised of leading experts in their respective fields of biochemistry, molecular biology, protein chemistry, bioinformatics, computer science and computational biology. They come to DoubleTwist from world-renowned institutions, including Stanford University, UCLA, UC Berkeley, UCSF, University of Pennsylvania, Sandoz Pharmaceutical, Onyx Pharmaceutical, Incyte, Molecular Simulations, Molecular Dynamics, Roche and Glaxo Wellcome. The company's software engineers have extensive experience in commercial-grade software systems, with particular expertise in relational database and object-oriented development. They come to DoubleTwist from some of the industry's most successful companies, including Apple, Oracle and IBM.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.